Amgen Inc. buy Royal Bank of Canada
Start price
24.01.25
/
50%
€262.90
Target price
24.01.26
€308.19
Performance (%)
6.81%
Price
18:30
€271.40
Summary
This prediction is currently active. With a performance of 6.81%, the BUY prediction by Royal_Bank_of_Canada for Amgen Inc. is trending in the right direction. A total of €9.41 was paid as dividends for this prediction. This prediction currently runs until 24.01.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -4.430% | -4.430% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $324.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat